The government is set to revive talks on the contentious issue of trade margin rationalisation (TMR) on drugs and medical devices with industry stakeholders at a meeting on May 16.

In this regard, the Department of Pharmaceuticals (DoP) and the National Pharmaceutical Pricing Authority (NPPA) have invited members of pharma associations and medical device manufacturers for the meeting and sought their suggestions by Friday.

“The DoP and NPPA have been receiving various suggestions from the industry for amendments in DPCO, 2013 and National Pharmaceutical Pricing Policy. Hence, it has been decided to organise a workshop with industry stakeholders with the participation of the associations of pharma and the medical device sector,” said the invite. The members of the lobby groups are expected to open up the discussion of introducing TMR on pharmaceutical formulations. Several small and medium pharma companies had also suggested that the government should adopt the ‘one-molecule, one-price’ formula.